The effect of thiamine consumption on liver microsomal drug-metabolizing pathways.
D000632:Aminopyrine / Q000378:metabolism; D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D001835:Body Weight; D003580:Cytochromes / Q000032:analysis; D004032:Diet; D004950:Esterases / Q000032:analysis; D005260:Female; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D006591:Hexobarbital / Q000378:metabolism; D007700:Kinetics; D008099:Liver / Q000201:enzymology; D008297:Male; D008862:Microsomes, Liver / Q000032:analysis / Q000201:enzymology / Q000378:metabolism*; D006899:Mixed Function Oxygenases / Q000032:analysis; D009249:NADP / Q000494:pharmacology; D009929:Organ Size; D010088:Oxidoreductases / Q000032:analysis; D010243:Paralysis; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010734:Phosphogluconate Dehydrogenase / Q000032:analysis; D051381:Rats; D012737:Sex Factors; D012890:Sleep; D013831:Thiamine / Q000378:metabolism*; D013832:Thiamine Deficiency / Q000503:physiopathology*; D015049:Zoxazolamine / Q000378:metabolism
D000814:Aniline Compounds; D003580:Cytochromes; D004364:Pharmaceutical Preparations; D000632:Aminopyrine; D009249:NADP; D015049:Zoxazolamine; D006591:Hexobarbital; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D004950:Esterases; D013831:Thiamine